Wuppertal, Germany

Michael Böttger

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 15.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Böttger: Innovative Mind in Pharmaceutical Chemistry

Introduction

Michael Böttger, an accomplished inventor based in Wuppertal, Germany, has made significant contributions to the field of pharmaceutical chemistry. With a total of two patents to his name, his work particularly focuses on treatments for diseases associated with angiogenesis and hyperproliferative disorders.

Latest Patents

Böttger's latest patents reflect his dedication to advancing medical science. One of his notable inventions is the patent for "Substituted pyridobenzodiazepinone-derivatives and use thereof." This invention pertains to novel (3-hydroxyphenyl)amino-substituted pyrido[2,3-b][1,5]benzodiazepin-5-one derivatives. The application highlights their use in treating and preventing diseases, especially those related to angiogenic disorders, cancers, and eye diseases. Treatments can be applied as monotherapy or in combination with other therapeutic measures.

His second patent, titled "Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors," focuses on 5-[(hydroxymethyl)aryl]-substituted pyrrolo[2,1-f][1,2,4]triazin-4-amines. This innovation includes the preparation processes for these compounds, as well as their pharmaceutical applications for treating angiogenesis-related disorders, particularly those affecting the eyes.

Career Highlights

Throughout his career, Michael Böttger has been affiliated with several esteemed companies. He contributed his expertise at Bayer Pharma AG and Bayer Intellectual Property GmbH, which are pivotal players in the pharmaceutical industry. His work in these organizations has significantly influenced the development of innovative medical solutions.

Collaborations

Böttger has also collaborated with notable professionals in the field, including Andreas Schall and Jürgen Klar. These collaborations have likely catalyzed the growth of his inventions, fostering an environment where ideas can flourish and result in impactful patent applications.

Conclusion

Michael Böttger stands out as a significant inventor in pharmaceutical chemistry. His innovative patents not only contribute to the scientific community but also pave the way for new treatments that can profoundly improve patient outcomes in challenging medical conditions. His career and collaborations further highlight the importance of teamwork and expertise in driving innovation in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…